Detection of AmpC Beta-lactamases in Gram Negative Bacilli - A Study from North India  by Gupta, V. et al.
13th International Congress on Infectious Diseases Abstracts, Poster Presentations e121
Methods: A total of 97 Pseudomonas aeruginosa strains
were isolated from various clinical specimens at the Kuala
Lumpur Hospital, Malaysia between October and December
2007. Antimicrobial susceptibility was determined using the
E-test method subsequent to the hospital’s routine diagnos-
tic testing by the disk diffusion (DD) method. Results were
interpreted according to the Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines.
Results: Total agreement of DD and E-test methods
was 99% for susceptibility to gentamicin, ciproﬂoxacin
and ceftazidime, 98% for susceptibility to amikacin,
piperacillin/tazobactam, imipenem and meropenem and
97% for susceptibility to cefepime. According to the
E-test method, the rates of susceptible isolates were
piperacillin/tazobactam 91%, amikacin 87%, gentamicin
85%, ciproﬂoxacin 84%, ceftazidime and cefepime 80% each,
imipenem 79% and meropenem 77%. 24% of the isolates were
resistant to two or more antimicrobial agents.
Conclusion: The E-test and DD methods showed high
agreement in determining the in vitro activity of the
antimicrobial agents on the Pseudomonas aeruginosa iso-
lates. Although the DD method is more cost effective for
routine hospital use, the E-test is rapid, easy to per-
form and has an added ability to determine MIC value.
Piperacillin/tazobactam was the most active antimicrobial
agent in vitro against Pseudomonas aeruginosa, followed
by the aminoglycosides (amikacin and gentamicin). By con-
trast, the quinolone (ciproﬂoxacin) and the beta-lactams
(meropenem, imipenem, cefepime and ceftazidime)were
the least active antimicrobial agents. Periodical surveillance
study of such provides very useful data on the overall situa-
tion in a hospital.
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Background: AmpC class beta lactamases are
cephalosporinases that are poorly inhibited by clavu-
lanic acid. They are different from other ESBLs by their
ability to hydrolyze Cephamycins (cefoxitin,cefotetan)
in addition to other extended spectrum cephalosporins.
Plasmid mediated Amp C beta lactamases differ from
chromosomal AmpCs in being uninducible and are typically
associated with broad multi drug resistance. Information on
the prevalence of AmpC beta lactamase producing strains
from India is scanty.
Here in we report a study done on gram negative bacilli
for AmpC detection using the previously reported AmpC disk
test from a tertiary public health care centre of North India.
Methods: The strains of gram negative bacilli included
42 Klebsiella pneumoniae, 2 Klebsiella oxytoca, 6 Proteus
mirabilis, 100 Salmonella typhi and 39 E. coli. Resistance to
cefoxitin was ﬁrst seen determined by disc diffusion test.
Only cefoxitin resistant isolates were further processed for
AmpC detection by the method of Amp C disc test. Positive
results were read as any indentation or ﬂattening of the
zone of inhibition. All the strains were also simultaneously
checked for ESBL production.
Results: Cefoxitin resistance was not detected in any
strain of Salmonella. Out of remaining 50 isolates exclud-
ing E. coli, Amp C was detected in 15 isolates-13 Klebsiella
pneumoniae, 1 Klebsiella oxytoca and 1 Proteus mirabilis.
10 showed indentation and 5 showed ﬂattening of the
zones. All the isolates were sensitive to Imipenem and vari-
ably sensitive to ciproﬂoxacin, cefoperazone-sulbactam and
aminoglycosides. Also regarding E. coli isolates 15 out of 39
showed AmpC disc test positivity.
Conclusion: 15/50 i.e (30%) of the Klebsiella pneumo-
niae, Klebsiella oxytoca, and Proteus mirabilis showed
prescence of AmpC from our centre, which is most proba-
bly plasmid mediated as these organisms lack chromosomal
AmpC. As regards E. coli, percentage positivity is about 45%,
but these could be plasmid or chromosomal.
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Background: Pseudomonas aeruginosa, recognized as
human opportunistic pathogen is increasingly responsible
for lethal nosocomial infections. Treatment options are dra-
matically declining worldwide. This species has emerged as
a relevant animal pathogen too. This is a consequence of
massive antibiotic use and the large versatile genome of
this organism. Antimicrobial proﬁling of P. aeruginosa ani-
mal isolates may contribute to a better understanding of the
development and the epidemiology of P. aeruginosa multi-
drug resistance in our densely populated biosphere with
increasing human-animal interactions.
Methods: This work characterized 66 P. aeruginosa
clinical isolates originating from diverse animals (horses,
cows, sea turtles, dolphins, cats, parrots, canguru,
etc.) using amongst others fAFLP (ﬂuorescent Ampliﬁed
Fragment Length Polymorphisms) ﬁngerprinting. Suscepti-
bility to 21 antibiotics (amikacin, amoxicillin/clavulanic
acid, ampicillin, chloranfenicol, carbenicillin, ceftazidime,
